New hope pill tested for tough blood cancers
Disease control
Not yet recruiting
This is a first-in-human study testing a new oral medication called APG-3288 for people with advanced blood cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will al…
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC